Principal Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-106,183	Closed	-$94.1K	–	2523
2022 Q4	$94.1K	Buy	106,183 +22,657	+27%	+$30.1K	﹤0.01%	2298
2022 Q3	$131K	Buy	83,526 +17,128	+26%	+$38.9K	﹤0.01%	2281
2022 Q2	$133K	Sell	66,398 -19,266	-22%	-$33.3K	﹤0.01%	2358
2022 Q1	$200K	Buy	85,664 +1,614	+2%	+$5.03K	﹤0.01%	2340
2021 Q4	$391K	Sell	84,050 -26,662	-24%	-$166K	﹤0.01%	2185
2021 Q3	$845K	Buy	110,712 +3,575	+3%	+$30.3K	﹤0.01%	2051
2021 Q2	$1.04M	Sell	107,137 -3,212	-3%	-$25.6K	﹤0.01%	2027
2021 Q1	$913K	Sell	110,349 -5,966	-5%	-$63K	﹤0.01%	2014
2020 Q4	$793K	Buy	116,315 +46,454	+66%	+$373K	﹤0.01%	1997
2020 Q3	$778K	Buy	69,861 +3,962	+6%	+$36.3K	﹤0.01%	1918
2020 Q2	$414K	Buy	65,899 +29,195	+80%	+$112K	﹤0.01%	2008
2020 Q1	$67K	Buy	36,704 +736	+2%	+$2.12K	﹤0.01%	2143
2019 Q4	$122K	Buy	35,968 +4,028	+13%	+$9.6K	﹤0.01%	2179
2019 Q3	$68K	Buy	31,940 +3,788	+13%	+$8.83K	﹤0.01%	2201
2019 Q2	$75K	Sell	28,152 -47,869	-63%	-$172K	﹤0.01%	2195
2019 Q1	$361K	Sell	76,021 -445	-0.6%	-$1.17K	﹤0.01%	1998
2018 Q4	$183K	Sell	76,466 -16,112	-17%	-$52.6K	﹤0.01%	2149
2018 Q3	$408K	Buy	92,578 +4,628	+5%	+$25.7K	﹤0.01%	2006
2018 Q2	$633K	Buy	+87,950	New	+$598K	﹤0.01%	1921